Why 23andMe Stock Scored an 11% Gain Today
Shares of genetic data miner 23andMe Holding (NASDAQ: ME) had surged 10.7% as of 12:45 p.m. EST Thursday in response to a mixed fiscal second-quarter 2022 earnings report featuring weaker revenue than predicted -- but a much lower loss than feared.
Heading into the quarter, analysts had forecast that 23andMe would lose $0.11 per share on sales of $55.7 million. 23andMe just missed hitting that sales number, reporting only $55.2 million in sales. However, the company's loss came to just $0.04 per share, beating expectations with one strand of DNA tied behind its back.
Image source: Getty Images.
Source Fool.com
